Evommune, Inc.

EVMNNYSEUSD
9.37 USD
0.62 (6.21%)AT CLOSE (11:59 AM EDT)
9.53
0.16 (1.70%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
9.53
0.16 (1.70%)
🔴Market: CLOSED

Evommune, Inc. (EVMN) trades at $9.55 per share. Technical indicators currently signal "Strong Sell". Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. EVMN is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Sep 16, 2026.

Open?$9.98
High?$9.99
Low?$9.30
Prev. Close?$9.99
Volume?568.9K
Avg. Volume?578.0K
VWAP?$9.55
Rel. Volume?0.98x
Bid / Ask
Bid?$9.37 × 100
Ask?$9.69 × 100
Spread?$0.32
Midpoint?$9.53
Valuation & Ratios
Market Cap?340.1M
Shares Out?N/A
Float?23.0M
Float %?63.5%
P/E Ratio?N/A
P/B Ratio?1.23
EPS?-$2.61
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Employees
48
Market Cap
362.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2025-11-06
Address
1891 PAGE MILL RD
PALO ALTO, CA
Phone: (650) 223-7745
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?18.95%High
Short Interest?4.4M
Days to Cover?11.6
Free Float23.0M
Avg Daily Volume375.2K
Settlement Date2026-08-31
Financial Health
Current Ratio?11.68Strong
Quick Ratio?11.68Strong
Cash Ratio?3.43Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
93
1.23CHEAP
P/S?
Peers
100
S&P
3
34.01HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-2.8CHEAP
EV/Sales?
Peers
100
S&P
3
28.05HIGH
Returns & Efficiency
ROE?
S&P
5
-34.1%WEAK
ROA?
S&P
3
-31.4%WEAK
Cash Flow & Enterprise
FCF?$-91096000
Enterprise Value?$280.5M
Fundamentals ratios updated end of day